© 2020 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
All News
Excerpts From Our Interview with Lisa Griffin of Jefferson Health
July 09, 2020
Excerpts from our interview of Lisa Griffin, senior vice president of front-end operation, at Jefferson Health,
Lisa Griffin of Jefferson Health Talks Telehealth, COVID-19 (Pt. 1)
July 09, 2020
Peter Wehrwein, senior editor at Managed Healthcare Executive, spoke with Lisa Griffin, senior vice president of front-end operations at Jefferson Health in Philadelphia, about the pivot to telehealth, "seamless access" and racism.
FDA Approves Hulio, the Sixth Biosimilar to Humira
July 08, 2020
Along with the other Humira biosimilars, Hulio will not be on the market till 2023.
Gravie Introduces First-Of-Its-Kind Zero-Copay,-Deductible Employer-Sponsored Health Plan
July 08, 2020
The new plan, called Gravie Comfort, offers 100% coverage on most common healthcare services, including preventive care, primary care, specialist visits, labs and imaging, generic prescriptions, online care, and more – all at a cost comparable to most traditional group health plans.
New USPSTF Lung Cancer Screening Recommendations Would Double Scans Among Blacks, Women
July 08, 2020
Lowering the age and smoking history standards would result in substantially more Blacks and women being eligible for screening.
New Joint Commission Requirements Likely to Boost Maternal Patient Safety
July 07, 2020
The outlook for decreasing the maternal mortality rate in the country has recently improved as a result of a recent initiative by the Joint Commission, which has developed 13 new elements of performance (EOPs) to help evaluate hospitals.
Culture-building is a Business Imperative Amid COVID-19
July 07, 2020
Crisis tests a business's culture. It also is a good time to create or strengthen a culture.
Short 'Bursts' of Oral Corticosteroids Are Associated With GI Bleeds, Other Adverse Events
July 07, 2020
The risk of long-term use of oral corticosteroids are well known. This research shows that short "bursts" of one to two weeks also carry some risk of adverse events.
Stat, Applied XL: COVID-19 Trials Too Small to Give Clear Answers
July 06, 2020
Almost 40% of trials are designed to have fewer than 100 patients.
Boosting Molecular Testing in Patients with GIST Would Have Minimal Cost Impact, Study Finds
July 06, 2020
Researchers cost-impact model calculates the cost to be 15 centers PMPY.